Venom from cone snails, scorpions, spiders, snakes and other species continue to provide an immense reservoir of potent bioactive peptides that target specific enzymes, ion channels and receptors. As such they represent major sources of lead compounds for both the development of pharmacological tools and novel drugs
Team Leader, Neurosciences: Institut de Génomique Fonctionelle de Montpellier, France
Proposed Talk: Low-voltage gated calcium channels in pain pathwys; from mecanism to toxin identification.
NHMRC R.D. Wright Biomedical Fellow: Visceral Pain Group, University of Adelaide, South Australian Health and Medical Research Institute (SAHMRI), Australia
Proposed Talk: Novel targets for the treatment of chronic visceral pain.
Camille and Henry Dreyfus Professor: Rockefeller University, USA
Proposed Talk: Rapid Production of versatile nanobody repertoires.
Professor of Pharmacology: Faculty of Pharmacy and Pharaceutical Sciences, Monash University, Australia
Proposed Talk: Allosteric targeting of G protein-coupled receptors.
Associate Professor of Bioengineering, Stanford University, USA
Proposed Talk: Engineered cystine knot peptides: A new class of targeting agents.
Professor of Pharmaceutical Neuroscience, The University of Sydney, Australia
Proposed Talk: Multiple binding interfaces on nACH receptors allude to stoichiometric dependent actions of antagonists.
Professor of Pharmacology: University College London, England
Proposed Talk: Regulation of voltage-gated calcium channel trafficking and function of α2δ subunits.
The Institute des Biomolécules Max Mousseron, Universite de Montpellier 2, France
Proposed Talk: Revision of prey capture and defence strategies in cone snails.
Group Leader: University of Queensland, Australia
Proposed Talk: Evolutionary toxinology: How to see the woods for the trees.
Professor: Monash Institute of Pharmaceutical Sciences, Monash University, Australia
Proposed Talk: New potassium channel blockers as treatments for autoimmune diseases: design, sysnthesis, stability and delivery.
Distinguished Professor: Department of Biology, The University of Utah, USA
Proposed Talk: Conus peptides, constellation pharmacology and heteromeric channel complexes.
President and CEO: Peptides International Inc., USA
Proposed Talk: Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.
Laboratory Head: Department of Biochemistry and Molecular Biology, Monash University, Australia
Proposed talk: Concerted actions and regiospecific expression of Conus foldases and enzymes underpins toxin biosynthesis.
Scientist II: Peptide Chemistry, MedImmune Ltd., Cambridge, U.K.
Proposed talk: Engineering Huwentoxin-IV.
Founder: Atheris Laboratories
Department Head: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia
Proposed Talk: From α-conotoxins, three-finger α-neurotoxins and Ly6 brain proteins to binding sites in nicotinic receptors
ARC Future Fellow and Group Leader: Institute for Molecular Bioscience, Australia
Proposed talk: Peripheral mechanisms of pain - insights from venom peptide ion channel modulators.
Assistant Member Medicinal Chemistry: Torrey Pines Institute for Molecular Biosciences
Proposed Talk: Synthetic conotoxin combinatorial libraries: discovery of novel nicotinic receptor igands for studying tobacco addiction and pain.
Professorial Research Fellow: Australian Institute of Tropical Health and Medicine
Proposed Talk: When structure leads to activity - analysis of a novel conotoxin.
Post Doctoral Fellow: Monash University
Proposed Talk: The structural basis of stonefish toxicity - high resolution insight into a pore-forming venom.
Professor of Physiology and Pharmacology: University of Calgary
Proposed Talk: An archtypical channel blocker with a split personality. µ-Conotoxin actions show new complexities when inhibiting a 'simple' prokaryotic sodium channel.
Professor of Pharmacology: University of Strathclyde, United Kingdom
Proposed Talk: From toxins to medicines: What are we doing wrong?
Assistant Professor: VU University Amsterdam, The Netherlands
Proposed Talk: Venom analytics for rapid identification and structural elucidation of bioactive peptides.
Deputy Director: St Vincents Institute of Medical Research
Proposed Talk: Cholesterol-dependent cytolysins: from soluble state to membrane pore.
Postdoctoral Fellow: Institute for Molecular Bioscience, Australia
Prooposed Talk: Semi-enzymatic cyclisation of kappa-conotoxin PVIIA, a peptide containing the inhibitory cystine knot motif.
Executive Director: TetraQ and Group Leader, Department of Pharmacy, The University of Queensland, Australia
Proposed Talk: Discovery and development of new pain medicines: Towards improving translational research outcomes.
PD Dr Med: Department of Anesthesia, University Clinic, Friedrich-Alexander-Universität Erlangen-Nürnburg, Germany
Proposed Talk: Botulinum Toxin-A treatment reduces cold responsiveness of cutaneous C-fiber nociceptors in vitro.